
Strategic Partners A/S
STRAP | CO
Overview
Corporate Details
- ISIN(s):
- DK0062502894 (+1 more)
- LEI:
- 54930025OZD2GGSQ7L42
- Country:
- Denmark
- Address:
- Lyskær 8 A st. tv., 2730 Herlev
- Website:
- https://www.orphazyme.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Orphazyme was founded in Denmark in 2009 on a scientific discovery about the role of heat shock proteins (HSPs), which was described in a well-cited article published in the journal Nature. We translated this scientific discovery into late-stage clinical trials of our investigational drug candidate, arimoclomol, with the aim of developing new treatment options for people with neurodegenerative diseases, such as Niemann-Pick disease type-C (NPC). In May 2022, substantially all of Orphazyme’s assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm, Inc.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-14 19:13 |
Major Shareholding Notification
|
Danish | 117.5 KB | |
2025-07-14 19:13 |
Major Shareholding Notification
|
Danish | 1.8 KB | |
2025-07-14 19:09 |
Directors' Dealings
|
Danish | 108.3 KB | |
2025-07-14 19:09 |
Directors' Dealings
|
Danish | 81.5 KB | |
2025-07-14 19:09 |
Directors' Dealings
|
Danish | 1.7 KB | |
2025-07-11 21:58 |
Directors' Dealings
|
Danish | 87.7 KB | |
2025-07-11 21:58 |
Directors' Dealings
|
Danish | 1.4 KB | |
2025-07-07 17:23 |
Transaction in Own Shares
|
Danish | 2.2 KB | |
2025-07-07 17:23 |
Transaction in Own Shares
|
Danish | 118.4 KB | |
2025-07-07 08:54 |
Transaction in Own Shares
|
Danish | 10.1 KB | |
2025-07-07 08:54 |
Transaction in Own Shares
|
Danish | 152.4 KB | |
2025-06-30 08:36 |
Transaction in Own Shares
|
Danish | 10.1 KB | |
2025-06-30 08:36 |
Transaction in Own Shares
|
Danish | 148.9 KB | |
2025-06-23 09:35 |
Transaction in Own Shares
|
Danish | 149.4 KB | |
2025-06-23 09:35 |
Transaction in Own Shares
|
Danish | 8.5 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |